
DISCO Pharmaceuticals gets $40M upfront from AbbVie and could earn up to $2.5B in milestones to develop AND-gated bispecifics for solid tumors.
The founder of five biotech companies rarely pauses, even to rest. "I can do a lot of work when the rest of my family is sleeping," he reports. "Early in the morning or late at night, there are no phones, so I needn't divert my attention." His affable tone seems contrary to the relentless drive needed to support a lifelong pursuit of excellence, but his achievements speak for themselves.
over 25 years ago
Industry Under Investigationover 25 years ago
Emotion - The New Brand Integratorover 25 years ago
For Love of the Gameover 25 years ago
Field of Dreamsover 25 years ago
Workshop: Access Optionsover 25 years ago
Emotion - The New Brand Integratorover 25 years ago
Rx-to-OTC: Unwanted Attentionover 25 years ago
Relocation: Coming to Americaover 25 years ago
Stocks: Catching the Market Bluesover 25 years ago
Gathering Light





